Atlas Trials

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Clinical trial NCT00005118 · UNKNOWN

Trial details

NCT number
NCT00005118
Sponsor
Merck Sharp & Dohme LLC
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.